Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACE-BEYOND: Tenecteplase for Acute Ischemic Stroke 24-72 Hours After Onset
NCT06954155Phase 3Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- May 2025
- Primary completion
- Feb 2027
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by Beijing Tiantan Hospital. Started May 2025; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06954155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06954155.